These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 25774783)
41. [Ursodeoxycholic acid, S-adenosyl-L-methionine and their combinations in the treatment of gestational intrahepatic cholestasis (ICP)]. Binder T; Salaj P; Zima T; Vitek L Ceska Gynekol; 2006 Mar; 71(2):92-8. PubMed ID: 16649407 [TBL] [Abstract][Full Text] [Related]
42. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review. Wu PA; Huang V; Bigby ME Br J Dermatol; 2014 May; 170(5):1015-20. PubMed ID: 24841586 [TBL] [Abstract][Full Text] [Related]
43. Association of conjugated linoleic acid consumption and liver enzymes in human studies: A systematic review and meta-analysis of randomized controlled clinical trials. Mirzaii S; Mansourian M; Derakhshandeh-Rishehri SM; Kelishadi R; Heidari-Beni M Nutrition; 2016 Feb; 32(2):166-73. PubMed ID: 26541717 [TBL] [Abstract][Full Text] [Related]
44. Efficacy of the dietary supplement S-adenosyl-L-methionine. Fetrow CW; Avila JR Ann Pharmacother; 2001 Nov; 35(11):1414-25. PubMed ID: 11724095 [TBL] [Abstract][Full Text] [Related]
45. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557 [TBL] [Abstract][Full Text] [Related]
46. [S-Adenosylmethionine: plasma levels in hepatic cirrhosis and preliminary results of its clinical use in hepatology. Double-blind study]. Ideo G Minerva Med; 1975 May; 66(33):1571-80. PubMed ID: 1095962 [TBL] [Abstract][Full Text] [Related]
47. Ursodeoxycholic acid for primary biliary cirrhosis. Gong Y; Huang ZB; Christensen E; Gluud C Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775 [TBL] [Abstract][Full Text] [Related]
48. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Mischoulon D; Fava M Am J Clin Nutr; 2002 Nov; 76(5):1158S-61S. PubMed ID: 12420702 [TBL] [Abstract][Full Text] [Related]
49. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis. Simko V; Michael S; Prego V Am J Gastroenterol; 1994 Mar; 89(3):392-8. PubMed ID: 8122652 [TBL] [Abstract][Full Text] [Related]
50. [A trial of using Geptral in patients with chronic liver diseases]. Gorbakov VV; Kalinin AV; Ermolin SN Voen Med Zh; 1996 Dec; 317(12):29-31. PubMed ID: 9163214 [No Abstract] [Full Text] [Related]
51. Chronic liver diseases and the potential use of S-adenosyl-L-methionine as a hepatoprotector. Mora SI; García-Román J; Gómez-Ñañez I; García-Román R Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):893-900. PubMed ID: 29683981 [TBL] [Abstract][Full Text] [Related]
52. SAMe: S-Adenosylmethionine. Chavez M Am J Health Syst Pharm; 2000 Jan; 57(2):119-23. PubMed ID: 10688238 [No Abstract] [Full Text] [Related]
53. Аdеmethionine in the treatment of fatigue in liver diseases: a systematic review. Raikhelson KL; Kondrashina EA Ter Arkh; 2019 Mar; 91(2):134-142. PubMed ID: 31094184 [TBL] [Abstract][Full Text] [Related]
54. Drug-induced Liver Disease in Patients with Diabetes Mellitus. Iryna K; Helen M; Elena S Euroasian J Hepatogastroenterol; 2015; 5(2):83-86. PubMed ID: 29201698 [TBL] [Abstract][Full Text] [Related]
55. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Noureddin M; Mato JM; Lu SC Exp Biol Med (Maywood); 2015 Jun; 240(6):809-20. PubMed ID: 25873078 [TBL] [Abstract][Full Text] [Related]